XML 68 R52.htm IDEA: XBRL DOCUMENT v3.25.1
EQUITY METHOD INVESTMENTS (Details Narrative)
12 Months Ended
Dec. 31, 2024
USD ($)
Dec. 31, 2024
CAD ($)
Dec. 31, 2024
EUR (€)
Dec. 31, 2023
USD ($)
Gain on extinguishment of debt $ 0     $ 1,910,967
Cosmo Farmacy LP [Member]        
Initial share capital | €     € 150,000  
Initial share capital increased | €     500,000  
Pharmacy license value | €     € 350,000  
Maturity period of license 30 years 30 years 30 years  
Ownership equity 70.00%      
Cash contributed to limited partner | €     € 150,000  
Equity ownership remaining 30.00%      
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member]        
Upfront cash received   $ 2,000,000    
Fair value of settlement account $ 1,554,590      
Gain on extinguishment of debt $ 1,554,590      
Agreement term five years five years five years  
Cash received upon gross sales   $ 2,750,000    
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales One [Member]        
Cash received upon gross sales   2,750,000    
Gross sales   13,000,000    
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales [Member]        
Cash received upon gross sales   2,750,000    
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales [Member]        
Gross sales   $ 6,500,000    
Share Exchange Agreement [Member] | ICC [Member]        
Investement $ 0     $ 160,470